EA200400783A1 - Средство для радикального лечения опухолей, воспалительных процессов, грибковых инфекций и других заболеваний тканей, их диагностика и профилактика и метод его применения - Google Patents
Средство для радикального лечения опухолей, воспалительных процессов, грибковых инфекций и других заболеваний тканей, их диагностика и профилактика и метод его примененияInfo
- Publication number
- EA200400783A1 EA200400783A1 EA200400783A EA200400783A EA200400783A1 EA 200400783 A1 EA200400783 A1 EA 200400783A1 EA 200400783 A EA200400783 A EA 200400783A EA 200400783 A EA200400783 A EA 200400783A EA 200400783 A1 EA200400783 A1 EA 200400783A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- tumors
- prevention
- fungal infections
- inflammatory processes
- radical treatment
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 206010017533 Fungal infection Diseases 0.000 title abstract 2
- 208000031888 Mycoses Diseases 0.000 title abstract 2
- 230000004054 inflammatory process Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000023555 blood coagulation Effects 0.000 abstract 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
- 208000026062 Tissue disease Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 230000002421 anti-septic effect Effects 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 210000004204 blood vessel Anatomy 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- 239000011630 iodine Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Изобретение относится к средствам для радикального лечения, диагностики и профилактики опухолей, воспалительных процессов, грибковых инфекций и других заболеваний тканей и к способу его применения. Оно основано на различной степени защиты, которую обеспечивают кровеносные сосуды здоровой и опухолевой ткани, против воздействия веществ, ускоряющих свертывание крови, на свойстве водного раствора муравьиной (метановой) кислоты различных концентраций ускорять свертывание крови, причем в большинстве случаев достаточна концентрация порядка 10% с добавлением или без добавления йода в концентрации около 5%, а также на сильном антисептическом и бактерицидном действии этих растворов.Международная заявка была опубликована вместе с отчетом о международном поиске.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BG106215A BG106215A (bg) | 2001-12-12 | 2001-12-12 | Средство за радикално лечение на туморите, възпалителни процеси, гъбични образувания и други изменения на тъканите, диагностика и профилактика и методи за прилагането му |
PCT/BG2002/000006 WO2003049728A1 (en) | 2001-12-12 | 2002-04-08 | Medium for radical treatment of tumors, inflammatory processes, fungal infections and other affections of the tissues, diagnostic and prophylactic and method of its implementation |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200400783A1 true EA200400783A1 (ru) | 2005-04-28 |
EA010029B1 EA010029B1 (ru) | 2008-06-30 |
Family
ID=3928598
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200400783A EA010029B1 (ru) | 2001-12-12 | 2002-04-08 | Способ лечения, диагностики и профилактики опухолевых, воспалительных и других заболеваний |
Country Status (11)
Country | Link |
---|---|
US (1) | US20050119344A1 (ru) |
EP (1) | EP1455772B1 (ru) |
AT (1) | ATE437635T1 (ru) |
AU (1) | AU2002245956A1 (ru) |
BG (1) | BG106215A (ru) |
DE (1) | DE60233161D1 (ru) |
DK (1) | DK1455772T3 (ru) |
EA (1) | EA010029B1 (ru) |
ES (1) | ES2332583T3 (ru) |
PT (1) | PT1455772E (ru) |
WO (1) | WO2003049728A1 (ru) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA201700154A1 (ru) * | 2014-10-20 | 2017-08-31 | Товарищество С Ограниченной Ответственностью "Фармацевтическая Компания "Ромат" | Фармацевтический состав лечебно-профилактического действия и способ его приготовления |
CN110545805A (zh) * | 2017-04-22 | 2019-12-06 | 秦才东 | 一种抑制细胞糖酵解过程的方法及应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4147775A (en) * | 1976-10-06 | 1979-04-03 | Schwartz Stephen H | Antiseptic composition |
LU86573A1 (de) * | 1986-09-08 | 1988-04-05 | Chimicasa Gmbh | Verfahren und praeparat zum inaktivieren von viren innerhalb lebender menschlicher oder tierischer organismen |
US4927813A (en) * | 1988-03-08 | 1990-05-22 | Bernstein Joel E | Method and composition for treating pediculosis capitis |
ATE155648T1 (de) * | 1992-09-22 | 1997-08-15 | Arda Technologies Co | Antimikrobielle zusammensetzung und verfahren zu ihrer herstellung |
WO1997041434A1 (en) * | 1996-04-30 | 1997-11-06 | Peregrine Pharmaceutical, Inc. | Method for diagnosing cancer |
US6231840B1 (en) * | 1998-02-13 | 2001-05-15 | Carol J. Buck | Compositions and methods for the topical treatment of nail fungi conditions |
SE513436C2 (sv) * | 1999-01-21 | 2000-09-11 | Astrid Agholme | Användning av en beredning innehållande myrsyra för framställning av ett läkemedel för behandling av vårtor, orsakade av Papillomavirus |
-
2001
- 2001-12-12 BG BG106215A patent/BG106215A/bg unknown
-
2002
- 2002-04-08 EP EP02713949A patent/EP1455772B1/en not_active Expired - Lifetime
- 2002-04-08 EA EA200400783A patent/EA010029B1/ru not_active IP Right Cessation
- 2002-04-08 DK DK02713949T patent/DK1455772T3/da active
- 2002-04-08 WO PCT/BG2002/000006 patent/WO2003049728A1/en not_active Application Discontinuation
- 2002-04-08 US US10/496,322 patent/US20050119344A1/en not_active Abandoned
- 2002-04-08 DE DE60233161T patent/DE60233161D1/de not_active Expired - Lifetime
- 2002-04-08 PT PT02713949T patent/PT1455772E/pt unknown
- 2002-04-08 AU AU2002245956A patent/AU2002245956A1/en not_active Abandoned
- 2002-04-08 ES ES02713949T patent/ES2332583T3/es not_active Expired - Lifetime
- 2002-04-08 AT AT02713949T patent/ATE437635T1/de active
Also Published As
Publication number | Publication date |
---|---|
EP1455772B1 (en) | 2009-07-29 |
AU2002245956A1 (en) | 2003-06-23 |
DE60233161D1 (de) | 2009-09-10 |
EA010029B1 (ru) | 2008-06-30 |
PT1455772E (pt) | 2009-11-03 |
US20050119344A1 (en) | 2005-06-02 |
EP1455772A1 (en) | 2004-09-15 |
DK1455772T3 (da) | 2009-11-30 |
WO2003049728A1 (en) | 2003-06-19 |
ES2332583T3 (es) | 2010-02-09 |
ATE437635T1 (de) | 2009-08-15 |
BG106215A (bg) | 2003-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005065242A3 (en) | Method of treating cancer using platelet releasate | |
DE60312309D1 (de) | Verwendung von botulinum toxin zur behandlung von herz- und kreislaufskrankheiten | |
DE60236413D1 (de) | Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten | |
ATE354380T1 (de) | Zusammensetzung zur prävention von infektionen durch subkutane prothesen | |
ES2195866T3 (es) | Composiciones acidas multiusos. | |
EA200100925A1 (ru) | Применение глицинбетаина в качестве антитромботического средства | |
DE60137635D1 (de) | Verwendung von allopurinol zur behandlung von bluthochdruck | |
DE69116380T2 (de) | Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit | |
ATE336997T1 (de) | Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen | |
ATE399002T1 (de) | Pharmazeutische zubereitungen für die behandlung von läsionen der haut und schleimhäute und diese verwendende verfahren und kits | |
MXPA05012392A (es) | Tratamientos de ansiedad con ziprasidona. | |
JP2016535044A (ja) | 次亜塩素酸ナトリウムを含む抗炎症溶液 | |
DE60122673D1 (de) | Methoden zur diagnose und behandlung von herzkrankheiten | |
EA200400783A1 (ru) | Средство для радикального лечения опухолей, воспалительных процессов, грибковых инфекций и других заболеваний тканей, их диагностика и профилактика и метод его применения | |
WO2003051383A3 (de) | Verwendung von hmgb-proteinen und dafür codierenden nukleinsäuren | |
RU2589682C1 (ru) | Отбеливающее средство | |
DE60204067D1 (de) | Verwendung von Xanthenon-4-Essigsäure zur Herstellung eines Medikaments für die Behandlung von hyperproliferativer Störungen | |
RU2006109966A (ru) | Препарат "янтастим-с" для терапии и профилактики инфекционных заболеваний животных | |
DE50111407D1 (de) | Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen | |
RU2229864C1 (ru) | Способ лечения инфекционных язв и кератитов | |
WO2022271810A3 (en) | Bicyclic peptidyl pan-ras inhibitors | |
US6932966B1 (en) | Topically applied reconstituted ocean water mixture and method of producing and using the mixture | |
DE60021111D1 (de) | Verwendung von fibrinolytischen metallproteinasen zur behandlung von blutgerinseln | |
WO2004112565A3 (en) | Diagnosis and treatment of liver, pulmonary and cardiac fibrosis | |
RU2726599C1 (ru) | Способ лечения ран |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): MD |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): TM |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ KZ KG TJ |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): BY RU |